Mark Copley, Sales Director at pharmaceutical testing equipment specialists Copley Scientific, is one of the invited speakers at the first Dry Powder Inhalation China Technology Conference which takes place in Shanghai on 18th and 19th April 2013. He will deliver a wide-ranging introduction to the in vitro testing of dry powder inhalers (DPIs), focusing on those aspects that are unique to this important category of orally inhaled drug product.
Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and Mark Copley is a well-known figure within the field. His presentation will cover both dose uniformity testing and aerodynamic particle sizing by cascade impaction, both of which yield data that are critical for the definition of product performance. A key focus will be the differences between methodologies for testing metered dose inhalers (MDIs), which are propellant driven, and those for DPIs. The majority of DPIs are considered passive devices, relying solely upon the strength of patient inhalation for successful drug delivery; a feature that has significant influence on the in vitro testing strategies applied.
Organised by DFE Pharma, the conference will examine the global DPI market but will focus on the development of DPI technology in China. Asthma and chronic obstructive pulmonary disease (COPD) are growing problems for the country but research into respiratory medicine has been relatively moderate and technology lags behind the levels seen elsewhere. In particular, DPIs can be used to replace MDIs that perform a vital healthcare role, but which still use environmentally damaging CFCs that need to be phased out. The event will draw together experts from across the globe to review best practice and emerging innovations, and to facilitate discussions on current and upcoming challenges for the respiratory and inhaled product industry.
For information about Copley Scientific products visit www.copleyscientific.com
About Copley Scientific
Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company is also active in detergent testing, air sampling and aerosol characterisation.
Copley Scientific’s pharmaceutical product range includes test equipment for: delivered dose uniformity and aerodynamic particle size measurement of metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays; as well as tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories and transdermals.
Copley Scientific has offices in the UK and Switzerland. The company works in partnership with aerosol particle science experts MSP Corporation in North America, and also distributes MSP Corporation’s air sampling and aerosol characterisation products throughout Europe.
Serving the pharmaceutical and associated industries, Copley Scientific offers an extensive range of equipment for research, development and quality control, as well as full validation and aftersales services. This broad range of products is supplied and supported worldwide through a network of specialist distributors. www.copleyscientific.com